| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/11/2006 | EP1613750A2 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 01/11/2006 | EP1613736A2 Inhibition of viral pathogenesis |
| 01/11/2006 | EP1613731A2 Modified adenoviral e1a constructs and methods of use thereof |
| 01/11/2006 | EP1613659A1 New monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 01/11/2006 | EP1613650A2 Severe acute respiratory syndrome (sars) causing coronavirus |
| 01/11/2006 | EP1613647A2 Use of hcv proteins |
| 01/11/2006 | EP1613642A2 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation |
| 01/11/2006 | EP1613369A2 Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives |
| 01/11/2006 | EP1613348A2 Methods for modulating angiogenesis with apelin compositions |
| 01/11/2006 | EP1613347A2 Humanized antibodies that recognize beta amyloid peptide |
| 01/11/2006 | EP1613346A2 Microfluidized oil-in-water emulsions and vaccine compositions |
| 01/11/2006 | EP1613345A2 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
| 01/11/2006 | EP1613344A2 Anti-tumor vasculature effects of human serum albumin derivatives |
| 01/11/2006 | EP1613273A2 Recombinant il-9 antibodies and uses thereof |
| 01/11/2006 | EP1613269A2 Compositions, methods and kits relating to her-2 cleavage |
| 01/11/2006 | EP1613262A2 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation |
| 01/11/2006 | EP1407033B1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 01/11/2006 | EP1372723B1 Semi-allogenic anti-tumour vaccine with hla haplo-identical antigen-presenting cells |
| 01/11/2006 | EP1303540B1 Multi-specific reagent for selective stimulation of cell surface receptors |
| 01/11/2006 | EP1240328B1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 01/11/2006 | EP1127064B1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 01/11/2006 | EP1113816B1 Influenza virus vaccine composition |
| 01/11/2006 | EP1104306B1 Compositions of cpg and saponin adjuvants and methods of use thereof |
| 01/11/2006 | EP1100537B1 Multivalent human-bovine rotavirus vaccine |
| 01/11/2006 | EP1073749B1 Enhancing immune responses to genetic immunization by using a chemokine |
| 01/11/2006 | EP1047422B1 Use of histamine for elevating blood histamine levels |
| 01/11/2006 | EP1012230B1 Renibacterium salmoninarum vaccine |
| 01/11/2006 | EP0830450B1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof |
| 01/11/2006 | EP0823913B1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 01/11/2006 | EP0821692B1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 01/11/2006 | EP0771352B1 Nontypable haemophilus influenzae lkp tip adhesin protein and nucleic acid |
| 01/11/2006 | EP0766569B1 Aav capsid vehicles for molecular transfer |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN1720336A Use of A33 antigens and JAM-IT |
| 01/11/2006 | CN1720262A Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 01/11/2006 | CN1720261A 疫苗 Vaccine |
| 01/11/2006 | CN1720060A Human papillomavirus polypeptides and immunogenic compositions |
| 01/11/2006 | CN1720045A Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases |
| 01/11/2006 | CN1718730A Anti tumour fusion protein and its coding gene and application |
| 01/11/2006 | CN1718587A Ant CD20 chimeric antibody |
| 01/11/2006 | CN1718245A Nucleic acid vaccine, and its application |
| 01/11/2006 | CN1718243A Immunological adjuvant, and its application in preparing vaccine and medicine for anti-virus |
| 01/11/2006 | CN1718242A Recombination vaccine of dog-2 type adenovirus for lyssic virus gluco-/nucleo-structured protein |
| 01/11/2006 | CN1236057C Recombinant gland related virus expressing human kallikrein, its preparation method and application |
| 01/11/2006 | CN1235911C Multiple cytokine-antibody complexes |
| 01/11/2006 | CN1235640C Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 01/11/2006 | CN1235639C Radiolabeling kit and binding assay |
| 01/10/2006 | US6984728 Recombinant infectious laryngotracheitis virus for use as tool in prevention of viral infections |
| 01/10/2006 | US6984726 Recombinant major allergen of the pollen of Artemisia vulgaris (mugwort) |
| 01/10/2006 | US6984721 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80 |
| 01/10/2006 | US6984720 cytotoxic t lymphocytes; immunology |
| 01/10/2006 | US6984625 Methods and compositions for modulating autoimmunity |
| 01/10/2006 | US6984522 Isolation and use of solid tumor stem cells |
| 01/10/2006 | US6984504 Ebola virion proteins expressed from venezuelan equine encephalitis (VEE) virus replicons |
| 01/10/2006 | US6984490 Identification of genes |
| 01/10/2006 | US6984389 Administering to a cancer patient at least one treatment modality, containing a tyrosine kinase inhibitor and a purified heat shock protein to cure the cancer |
| 01/10/2006 | US6984388 highly protective, live vaccine contains an ampicillin ( beta -lactam)-resistant mutant of Flavobacterium columnare, protects catfish against infection |
| 01/10/2006 | US6984387 Immunogenic peptides of foot-and-mouth disease viruses |
| 01/10/2006 | US6984386 Nanoparticle covering with non-plant virion coat protein shell; prepare by incubation, adjusting PH, control opening an entry on virion to confine, trap the mineral inside; magnetic resonance imaging, contrasting agents, drug delivery |
| 01/10/2006 | US6984385 Immunological combination compositions and methods |
| 01/10/2006 | US6984384 A biodrug mixture contains a preheated fusion protein,comprising heat shock protein, glucose-regulated protein and immuogens; antigrowth agents; cancer, tuberculosis infection |
| 01/10/2006 | US6984383 Method of transplanting cells by contacting donor cells with B7-1-and B7-2-specific immunoglobulins |
| 01/10/2006 | US6984382 Bifunctional protein, preparation and use |
| 01/10/2006 | US6984381 Immunizing against STaphylococcus infections |
| 01/10/2006 | CA2189831C Dna-based vaccination of fish by immersion |
| 01/10/2006 | CA2081043C Antitumor vaccines comprising il-6 transfected cells |
| 01/05/2006 | WO2006002438A2 Human monoclonal antibodies to fc gamma receptor i (cd64) |
| 01/05/2006 | WO2006002437A2 Treatment of conditions involving demyelination |
| 01/05/2006 | WO2006002377A2 Optimized dosing with anti-cd4 antibodies for tolerance induction in primates |
| 01/05/2006 | WO2006002248A1 Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 01/05/2006 | WO2006002193A2 Prrsv subunit vaccines |
| 01/05/2006 | WO2006002160A1 Vaccination of skunks and/or mongooses against rabies |
| 01/05/2006 | WO2006002151A1 Plasma detoxification and volume control system and methods of use |
| 01/05/2006 | WO2006002058A2 Treatment of autism |
| 01/05/2006 | WO2006002057A2 Treatment of acne |
| 01/05/2006 | WO2006001848A2 Quantum dots as high-sensitivity optical sensors and biocompatible imaging probes, compositions thereof, and related methods |
| 01/05/2006 | WO2006000920A2 Dimensional analysis of saccharide conjugates with gpc & sec-mals |
| 01/05/2006 | WO2005112990A3 Treatment of diseases associated with the use of antibiotics |
| 01/05/2006 | WO2005081854A3 Egf receptor epitope peptides and uses thereof |
| 01/05/2006 | WO2005063292A8 Heh4 molecules and uses thereof |
| 01/05/2006 | WO2005060995A8 Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| 01/05/2006 | WO2005049073A3 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 01/05/2006 | WO2005037320A3 Process for preparing polysaccharide-protein conjugate vaccines |
| 01/05/2006 | WO2005030793A3 Antibodies which bind human cxcr3 |
| 01/05/2006 | WO2005028433A3 CRIPTO ANTAGONISM OF ACTIVIN AND TGF-β SIGNALING |
| 01/05/2006 | WO2005011571A3 Hepatitis virus core proteins as vaccine platforms and methods of use thereof |
| 01/05/2006 | WO2005001029A3 Ancestral viruses and vaccines |
| 01/05/2006 | WO2004078146A3 Trans-membrane-antibody induced inhibition of apoptosis |
| 01/05/2006 | WO2004071441A3 Compositions and methods to modulate immune and inflammatory responses |
| 01/05/2006 | WO2004066928A3 Use of mycobacterial vaccines in cd4+ or cd8+ lymphocyte-deficient mammals |
| 01/05/2006 | WO2004025267A3 Method for testing drug susceptibility of hiv |
| 01/05/2006 | WO2004016743A3 Culturing anaplasma |
| 01/05/2006 | WO2003102153A3 Cell migration inhibiting compositions and methods and compositions for treating cancer |
| 01/05/2006 | WO2003095477A3 Miniprotein ligands and other polypeptides and methods for making and using same |
| 01/05/2006 | WO2003016493A3 Transporters and ion channels |
| 01/05/2006 | US20060004188 Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance |
| 01/05/2006 | US20060004186 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use |
| 01/05/2006 | US20060004184 Method and device for detecting feline immunodeficiency virus |
| 01/05/2006 | US20060004019 Steroid sparing agents and methods of using same |
| 01/05/2006 | US20060003961 Negative regulation of hypoxia inducible factor 1 by OS-9 |